Clinical Trial Update: Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the Trimer 4571 therapeutic vaccine in adults living with HIV on suppressive antiretroviral therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Trimer 4571 (Env protein trimer)

Snippet

Sponsor: Madhu Chhanda Choudhary | Conditions: HIV Infections | Phase 1 | Status: COMPLETED